Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.

Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.

Item
http://www.wikidata.org/entity/Q37707726
Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcuminEffect of the Pleiotropic Drug CNB-001 on Tissue Plasminogen Activator (tPA) Protease Activity in vitro: Support for Combination Therapy to Treat Acute Ischemic Stroke.Effect of curcumin supplementation on physiological fatigue and physical performance in mice.Protective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed RatsMitochondrial aldehyde dehydrogenase obliterates insulin resistance-induced cardiac dysfunction through deacetylation of PGC-1α.Curcumin Promotes Cell Cycle Arrest and Inhibits Survival of Human Renal Cancer Cells by Negative Modulation of the PI3K/AKT Signaling Pathway.Curcumin and insulin resistance-Molecular targets and clinical evidences.Furostanolic saponins from Trigonella foenum-graecum alleviate diet-induced glucose intolerance and hepatic fat accumulation.4-((1E)-2-(5-(4-hydroxy-3-methoxystyryl-)-1-phenyl-1H-pyrazoyl-3-yl) vinyl)-2-methoxy-phenol) (CNB-001) Does Not Regulate Human Recombinant Protein-Tyrosine Phosphatase1B (PTP1B) Activity in vitro.Spectroscopic and biological activity studies of the chromium-binding peptide EEEEGDD.
P2860

Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.

Item
http://www.wikidata.org/entity/Q37707726
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.
@en
Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.
@nl
type
label
Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.
@en
Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.
@nl
prefLabel
Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.
@en
Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932